EUVIMEDEUVIMED entdecken
Crossref

Indole-3-propionic acid protects medium-diversity colitic mice via barrier enhancement preferentially over anti-inflammatory effects

Kristoff M Nieves, Kyle L Flannigan, Elizabeth Hughes, Matthew Stephens iD, Andrew J Thorne iD, Ameline Delanne-Cuménal, Kathryn Strayer iD, Darasimi Kola-Ilesanmi iD, Senya Wickramasinghe, Niloofar Mirzadzar, Grace Baruta, Braedon McDonald und 4 weitere

American Journal of Physiology-Gastrointestinal and Liver Physiology · 2025

DOI: 10.1152/ajpgi.00256.2024 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Physiology-Gastrointestinal and Liver Physiology, 2025. Verfasst von Kristoff M Nieves und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology & Pharmacology, University of Calgary, Calgary, Alberta, Canada. Hauptthemen laut MEDLINE: Indoles, Colitis, Gastrointestinal Microbiome, Intestinal Mucosa. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: Crohn's and Colitis Canada (Crohn et Colite Canada), Crohn's and Colitis Foundation (CCF), U.S. Department of Defense (DOD).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Indole-3-propionic acid (IPA) is a metabolite produced by the intestinal microbiota that has been shown to elicit beneficial effects in the gastrointestinal (GI) tract that include regulating intestinal barrier function, reducing inflammation, and controlling immune responses that lead to fibrosis. In patients with inflammatory bowel disease (IBD), IPA levels are reduced. In the current study, we found that treating mice with IPA at the peak of intestinal inflammation improved clinical outcomes and disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

IndolesColitisGastrointestinal MicrobiomeIntestinal MucosaColonAnti-Inflammatory AgentsAnimalsMiceDextran SulfateMice, Inbred C57BLPropionatesGerm-Free LifeMaleDisease Models, Animal

Stichwörter der Autor:innen

colitisepitheliumindole-3-propionic acidmicrobiota

Substanzen

IndolesDextran Sulfateindolepropionic acidAnti-Inflammatory AgentsPropionates

Autor:innen und Institutionen

  • Department of Physiology & Pharmacology, University of Calgary, Calgary, Alberta, Canada.
  • Snyder Institute for Chronic Diseases, University of Calgary, Calgary, Alberta, Canada.
  • Department of Critical Care Medicine, University of Calgary, Calgary, Alberta, Canada.
  • Faculty of Veterinary Medicine, University of Calgary, Calgary, Alberta, Canada.
  • Department of Medicine, University of Calgary, Calgary, Alberta, Canada.
  • Department of Microbiology, Immunology and Infectious Diseases, University of Calgary, Calgary, Alberta, Canada.

ORCID-Profile: Matthew Stephens, Andrew J Thorne, Kathryn Strayer, Darasimi Kola-Ilesanmi, Simon A Hirota

Förderung

  • Crohn's and Colitis Canada (Crohn et Colite Canada)
  • Crohn's and Colitis Foundation (CCF)
  • U.S. Department of Defense (DOD)
  • Canadian Government | CIHR | Canadian Institutes of Health Research - Antimicrobial Resistance Research Initiative (AMR)
  • NCI NIH HHS
  • HHS | NIH | NIDDK | Division of Diabetes, Endocrinology, and Metabolic Diseases (DEM)

Zitieren

APA

Nieves, K. M., Flannigan, K. L., Hughes, E., Stephens, M., Thorne, A. J., Delanne-Cuménal, A., Strayer, K., Kola-Ilesanmi, D., Wickramasinghe, S., Mirzadzar, N., Baruta, G., McDonald, B., Cobo, E. R., Petri, B., Mani, S., & Hirota, S. A. (2025). Indole-3-propionic acid protects medium-diversity colitic mice via barrier enhancement preferentially over anti-inflammatory effects. American Journal of Physiology-Gastrointestinal and Liver Physiology. https://doi.org/10.1152/ajpgi.00256.2024

Vancouver

Nieves KM, Flannigan KL, Hughes E, Stephens M, Thorne AJ, Delanne-Cuménal A, et al. Indole-3-propionic acid protects medium-diversity colitic mice via barrier enhancement preferentially over anti-inflammatory effects. American Journal of Physiology-Gastrointestinal and Liver Physiology. 2025. doi:10.1152/ajpgi.00256.2024

BibTeX
@article{Nieves2025,
  author = {Nieves, Kristoff M and Flannigan, Kyle L and Hughes, Elizabeth and Stephens, Matthew and Thorne, Andrew J and Delanne-Cuménal, Ameline and Strayer, Kathryn and Kola-Ilesanmi, Darasimi and Wickramasinghe, Senya and Mirzadzar, Niloofar and Baruta, Grace and McDonald, Braedon and Cobo, Eduardo R and Petri, Björn and Mani, Sridhar and Hirota, Simon A},
  title = {Indole-3-propionic acid protects medium-diversity colitic mice via barrier enhancement preferentially over anti-inflammatory effects},
  journal = {American Journal of Physiology-Gastrointestinal and Liver Physiology},
  year = {2025},
  doi = {10.1152/ajpgi.00256.2024}
}
Kostenlos starten →